Reading ALB? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ALB free→Reading ALB? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ALB free→QuarterlyIQ Insights · ALB
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously reported, Donald J. LaBauve Jr., the former Chief Accounting Officer of Albemarle Corporation (the “Company”), retired on June 1, 2026. Neal R. Sheorey, the Company's Executive Vice President and Chief Financial Officer, will serve as the Company's interim Principal Accounting Officer, effective June 2, 2026, until the Company’s Board…
The excerpt is incomplete and does not provide specific details about the management change.
Results of Operations and Financial Condition. On May 6, 2026 , Albemarle Corporation (the “Company”) issued a press release reporting its results for the first quarter ended March 31, 2026. A copy of this release is being furnished as Exhibit 99.1 hereto and incorporated herein by reference. In addition, on May 7, 2026, the Company will hold a teleconference for analysts and media to discuss results for the first quarter ended March 31, 2026. The teleconference will be webcast on the Company…
Chief Accounting Officer — Donald J. LaBauve Jr.: Mr. LaBauve is retiring after more than 36 years of service.
Entry into a Material Definitive Agreement. On March 19, 2026, Albemarle Corporation (the “Company”), Albemarle Europe Srl, the lenders party thereto and Bank of America, N.A., as administrative agent, entered into the third amendment (the “Third Amendment”) to that certain amended and restated credit agreement dated as of October 28, 2022, as previously amended on February 9, 2024 and October 31, 2024 (the “2022 Credit Agreement”). The Third Amendment modifies the 2022 Credit Agreement by, a…
Other Events. On March 2, 2026, the Company issued a press release announcing the redemption of its 4.650% Senior Notes due 2027 and its offers to purchase for cash up to an aggregate purchase price of $500 million for (i) its 5.65% Senior Notes due 2052, (ii) its 5.45% Senior Notes due 2044, (iii) the 3.45% Senior Notes due 2029 of Albemarle Wodgina Pty Ltd, a wholly-owned subsidiary of the Company, and (iv) its 5.05% Senior Notes due 2032, upon the terms and subject to the conditions set fo…
Completion of Acquisition or Disposition of Assets. On March 2, 2026, Albemarle Corporation, a Virginia corporation (the “Company” or “Albemarle”), completed the previously announced sale of its 51% ownership interests (the “Sale”) in Ketjen Corporation, a Delaware corporation (“Ketjen”), to ChemCat AcquisitionCo, LLC, a Delaware limited liability company organized by and affiliated with KPS Capital Partners LP, a New York based private equity firm. Ketjen’s business consists of developing, m…
Director — Ms. Michelle T. Collins and Mr. Mark R. Widmar: Two new independent directors were appointed to the Board.
Results of Operations and Financial Condition. On February 11, 2026 , Albemarle Corporation (the “Company”) issued a press release reporting its results for the fourth quarter ended December 31, 2025. A copy of this release is being furnished as Exhibit 99.1 hereto and incorporated herein by reference. In addition, on February 12, 2026, the Company will hold a teleconference for analysts and media to discuss results for the fourth quarter and fiscal year ended December 31, 2025. The teleconfe…
Director — Dean L. Seavers: Dean L. Seavers resigned from the Board of Directors and all committees.
Results of Operations and Financial Condition. On November 5, 2025 , Albemarle Corporation (the “Company”) issued a press release reporting its results for the third quarter ended September 30, 2025. A copy of this release is being furnished as Exhibit 99.1 hereto and incorporated herein by reference. In addition, on November 6, 2025, the Company will hold a teleconference for analysts and media to discuss results for the third quarter ended September 30, 2025. The teleconference will be webc…
Material Impairments. In connection with the transactions described under
Entry into a Material Definitive Agreement. On October 25, 2025, Albemarle Corporation, a Virginia corporation (the “Albemarle”), Ketjen Corporation, a Delaware corporation (“Ketjen”) that is a wholly-owned subsidiary of Albemarle, and ChemCat AcquisitionCo, LLC, a Delaware limited liability company (the “Purchaser”), entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) pursuant to which Albemarle agreed to pursue a series of transactions that will result in the sale of a…
below) and the transfer of its performance catalysts solutions business to Albemarle or one or more of its affiliates. Ketjen’s business at the closing of the Transaction will consist of developing, manufacturing (including through toll manufacturing arrangements), and marketing catalysts and related products on a global basis. The Transaction is expected to close in the first half of 2026 upon the satisfaction or waiver of the closing conditions contained in the Stock Purchase Agreement. Und…
Chief Operations Officer — Netha N. Johnson: The Chief Operations Officer is departing and a new COO has been appointed.
President and Chief Executive Officer and Chairman of the Board — J. Kent Masters: The employment agreement was extended for Mr. Masters, providing continuity and updated compensation terms.
Results of Operations and Financial Condition. On July 30, 2025 , Albemarle Corporation (the “Company”) issued a press release reporting its results for the second quarter ended June 30, 2025. A copy of this release is being furnished as Exhibit 99.1 hereto and incorporated herein by reference. In addition, on July 31, 2025, the Company will hold a teleconference for analysts and media to discuss results for the second quarter ended June 30, 2025. The teleconference will be webcast on the Com…
Results of Operations and Financial Condition. On April 30, 2025 , Albemarle Corporation (the “Company”) issued a press release reporting its results for the first quarter ended March 31, 2025. A copy of this release is being furnished as Exhibit 99.1 hereto and incorporated herein by reference. In addition, on May 1, 2025, the Company will hold a teleconference for analysts and media to discuss results for the first quarter ended March 31, 2025. The teleconference will be webcast on the Comp…
Results of Operations and Financial Condition. On February 12, 2025 , Albemarle Corporation (the “Company”) issued a press release reporting its results for the fourth quarter ended December 31, 2024. A copy of this release is being furnished as Exhibit 99.1 hereto and incorporated herein by reference. In addition, on February 13, 2025, the Company will hold a teleconference for analysts and media to discuss results for the fourth quarter and fiscal year ended December 31, 2024. The teleconfe…
Results of Operations and Financial Condition. On November 6, 2024 , Albemarle Corporation (the “Company”) issued a press release reporting its results for the third quarter ended September 30, 2024. A copy of this release is being furnished as Exhibit 99.1 hereto and incorporated herein by reference. In addition, on November 7, 2024, the Company will hold a teleconference for analysts and media to discuss results for the third quarter ended September 30, 2024. The teleconference will be webc…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 28, 2024, Albemarle Corporation (the “Company”) appointed Donald J. LaBauve, Jr. (Jim) as the Company’s Chief Accounting Officer, effective November 11, 2024. In connection with his appointment, Mr. LaBauve will assume the role of the Company’s principal accounting officer. As previously announced, John C. Barichivich III will cease serv…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 7, 2024, in connection with the implementation of the new operating structure described in
of Form 8-K and shall not be deemed “filed” for the purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing. Cautionary Statement Regarding Forward -Looking Statements This Current Report on Form 8-K contains statements concerning Albemarle’s and its subsidiaries’ exp…
Results of Operations and Financial Condition. On July 31, 2024 , Albemarle Corporation (the “Company”) issued a press release reporting its results for the second quarter ended June 30, 2024. A copy of this release is being furnished as Exhibit 99.1 hereto and incorporated herein by reference. In addition, on August 1, 2024, the Company will hold a teleconference for analysts and media to discuss results for the second quarter ended June 30, 2024. The teleconference will be webcast on the Co…
Results of Operations and Financial Condition. On May 1, 2024 , Albemarle Corporation (the “Company”) issued a press release reporting its results for the first quarter ended March 31, 2024. A copy of this release is being furnished as Exhibit 99.1 hereto and incorporated herein by reference. In addition, on May 2, 2024, the Company will hold a teleconference for analysts and media to discuss results for the first quarter ended March 31, 2024. The teleconference will be webcast on the Company…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.